Indian equity benchmarks rebounded on March 20, with the Nifty 50 rising half a percent following a more than 3 percent correction in the previous session. According to reports from Moneycontrol, market breadth turned positive with 1,721 shares advancing against 1,258 declining shares on the NSE. Despite this bounce back, the market is likely to be dominated by bears, with the previous week's low at risk. The recovery comes amid broader market weakness, with experts suggesting short-term trading opportunities across select stocks. However, as per The Times of India, markets have witnessed very little tolerance for uncertainty, with the sharp escalation in West Asia tensions since February 28 keeping risk appetite firmly subdued. The Nifty has witnessed a steep correction of over 2,000 points since the onset of the conflict, reflecting sustained pressure from adverse global cues and pronounced risk-off sentiment among investors.
Chennai Petroleum Corporation is positioned for potential upside momentum with technical indicators supporting a bullish outlook. As reported by Axis Securities, the stock is trending higher on the daily chart with a series of higher tops and higher bottoms, indicating a sustained strong uptrend. The stock is well placed above its 20-, 50-, 100- and 200-day simple moving averages, with rising volumes over the past four weeks signifying increased participation. The weekly chart shows the stock approaching a 'multiple resistance breakout' at ₹1,090–1,100 levels, with analysts recommending a buy strategy targeting ₹1,150 and ₹1,230 with a stop-loss at ₹1,010.
Coal India presents a compelling buy opportunity following its sustained performance above key resistance levels. According to Axis Securities, the stock is firmly sustaining above the multiple resistance zone of ₹440 on a closing basis, accompanied by rising volumes over the past three weeks. The stock maintains position above its 20-, 50-, 100- and 200-day simple moving averages, with rising volumes over the past four weeks indicating increased participation. Technical analysts recommend a buy strategy targeting ₹490 and ₹515 with a stop-loss at ₹445.
Bharti Airtel has shown relative strength after approaching key support levels, with technical analysis suggesting potential for a primary uptrend resumption. As reported by Angel One, the stock is positioned around the 89-week EMA, which aligns with previous breakout levels near ₹1,780, along with a Price Reversal Zone derived from a bullish AB=CD pattern. The setup includes a tweezer bottom formation at support levels, indicating favorable risk-reward opportunity in the ₹1,846–1,840 range with a target of ₹1,950 and stop-loss at ₹1,796.
Aurobindo Pharma continues to exhibit strong performance in the pharma sector, outperforming amid broader market weakness. According to Angel One, the stock is trading in a higher top–higher bottom formation with every dip towards the 20-day EMA being consistently bought. On the weekly chart, the stock has confirmed a breakout from a year-long consolidation and is currently trading around its breakout zone. The RSI indicates a strong bullish range shift, with analysts recommending a buy strategy around ₹1,290–1,280 targeting ₹1,400 with a stop-loss at ₹1,240.
JB Chemicals and Pharmaceuticals has been consistently holding above its 20-day EMA since forming a bullish flag-and-pole pattern on March 2nd, with this level acting as a strong dynamic support. As per The Times of India, the price structure remains constructive, highlighting sustained buying interest on dips. With Friday's close above the Bollinger Bands midline, the bullish bias has further strengthened. Notably, the rising ratio line in JBCHEPHARM/NIFTY ratio chart signals clear relative outperformance versus the benchmark Index. Analysts recommend accumulating the stock in the zone of ₹2,134-2,144 with a stop-loss of ₹2,075, targeting ₹2,290 in the short term.
